Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

Pioglitazone use was linked to hair regrowth in a patient with permanent hair loss from cicatricial alopecia.

The Blood Glucose Management Service improved patient safety and outcomes in managing blood sugar in hospitalized patients.

A patient's hair loss may be linked to their diabetes medication, Sitagliptin.

GLP-1 RA medications may be linked to hair loss.

GLP-1 RAs help with diabetes and skin issues but can cause skin reactions and surgery challenges.

GLP-1 agonists may help treat certain skin conditions.

Empagliflozin helps heal diabetic wounds in rats by reducing inflammation and oxidative stress.

GLP-1 receptor agonists for weight loss may cause hair loss, especially in women.

Continuous glucose monitoring and GLP-1 receptor agonists improve diabetes management, but personalized care and education are crucial.

Lifestyle changes are more effective than medication for reducing type 2 diabetes risk.

Inhibitors of 11β-HSD1 show potential for treating type 2 diabetes but require more testing for safety and effectiveness.

Pioglitazone, Trimipramine, and Dimetindene may be repurposed to treat psoriasis.

GLP-1 receptor agonists can both help and harm hair, so careful monitoring is needed.

Metformin helps manage weight, blood pressure, and hormonal imbalances in PCOS patients.

GLP-1 receptor agonists can help manage PCOS metabolism but need careful use before conception.

Finasteride may worsen blood sugar control in diabetic patients.

Metformin can help prevent the side effects of glucocorticoid medications on metabolism.

Lifestyle changes are more effective than metformin in reducing type 2 diabetes risk in women with PCOS.

Lifestyle changes are more effective than medication for reducing type 2 diabetes risk.

Semaglutide helps obese PCOS patients lose weight and improve health.

GLP-1 receptor agonists may cause hair loss, but regrowth is rare.

Self-monitoring blood pressure in pregnant women didn't improve outcomes, diabetes drugs may increase gallbladder disease risk, a new drug helps severe hair loss, a plant-based COVID-19 vaccine is 69.5% effective, and new anticoagulants are safer for diabetics with heart rhythm issues than warfarin.

Lifestyle changes are more effective than medication for reducing type 2 diabetes risk.

Linagliptin may cause hair loss and skin blisters.

Tridax procumbens significantly lowers blood sugar in diabetic rats.

GLP-1 receptor agonists help with weight loss but need to be combined with other treatments for best results.

Drugs that block GSK-3 show promise for treating various diseases.